Posts - CLL Support | HealthUnlocked
All posts for May 2013
Want to take advantage of all our features? Just log in!
or
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia...
This paper reviews the preclinical and clinical data for ibrutinib when used in ...
Macmillan, Challenge The Caring Crisis
"Almost a million people in England help care for a friend or family member with...
With Money at Risk, Hospitals Push Staff to Wash Hands
Interesting recent New York Times article on what some NY hospitals are doing to...
Tips for getting through treatment from Patients Against Lymphoma
Karl Schwartz, the president of Patients Against Lymphoma has just drawn attenti...
ASCO 2013: ABT-199 in relapsed and refractory disease
Friends
I just posted my review of some pretty promising data on ABT-199 in d...
Immunocompromised Travelers
The busy travel season is beginning soon, in the Northern Hemisphere, worth revi...
Dr Sharman explains how to find open trials using clinicaltrials.gov
If you are prepared to consider joining a trial to research hopefully improved t...
CLL Support Association Newsletter.
The Spring 2013 edition of the CLL Support Association Newsletter is now availab...
Dr Sharman begins blogging on relevant ASCO papers
Dr Sharman blogged last Wednesday: "ASCO abstracts are out. It feels like Chris...
Genentech has announced an Expanded Access Program (EAP) for Obinutuzumab (GA101)
Update...Dr. Sharman has a post on this monoclonal...
http://www.cll-nhl.com/20...